Reuters -- Iceland’s Actavis will forgo backing from Swedish buyout firm EQT as it prepares to square off against larger peer Teva (TEVA.TA) in the bidding for generic drug maker Ratiopharm, several people familiar with the auction said.
Reuters -- Iceland’s Actavis will forgo backing from Swedish buyout firm EQT as it prepares to square off against larger peer Teva (TEVA.TA) in the bidding for generic drug maker Ratiopharm, several people familiar with the auction said.
